Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo
- PMID: 20210245
- DOI: 10.1177/030089160909500623
Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo
Abstract
Aims and background: Tanshinone II-A is an alcohol extract of the root of the traditional Chinese medicinal plant Salvia miltiorrhiza Bunge, whose effects and mechanism in tumor metastasis are still unclear. The aim of this study was to investigate the effects of tanshinone II-A on tumor invasion and metastasis in human hepatocellular carcinoma (HCC) and its possible mechanism of action.
Methods and study design: The HCC cell lines HepG2 and SMMC-7721 were treated with tanshinone II-A at different doses. Invasion and metastasis of tumor cells were examined by in vitro and in vivo assays. The molecular mechanisms of tanshinone II-A for inhibiting invasion and metastasis of HCC cells were investigated by Western blot and gelatin zymography.
Results: Treatment with tanshinone II-A had inhibitory effects on the migration and invasion of HCC cells. Increasing doses resulted in enhanced inhibitory effects. At 0.5 mg/L, the inhibitory effect was noticeable. At 1 mg/L, the inhibitory rate was 53.15%. The inhibitory effect became stronger with time; among 24, 48, 72 and 96 hours of treatment, the most significant effects were observed at 72 hours. Tanshinone II-A also significantly inhibited in vivo metastasis of HepG2 cells. Tanshinone II-A inhibited in vitro and in vivo invasion and metastasis of HCC cells by reducing the expression of the metalloproteinases MMP2 and MMP9 and by blocking NF-kappa B activation.
Conclusions: Tanshinone II-A effectively inhibited invasion and metastasis of HCC cells in vitro and in vivo, partly by inhibiting the activity of MMP2 and MMP9, and partly via the NF-kappa B signal transduction pathway.
Similar articles
-
Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.Acta Pharmacol Sin. 2009 Nov;30(11):1537-42. doi: 10.1038/aps.2009.139. Epub 2009 Oct 12. Acta Pharmacol Sin. 2009. PMID: 19820721 Free PMC article.
-
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.Br J Pharmacol. 2014 Jun;171(12):3037-50. doi: 10.1111/bph.12626. Br J Pharmacol. 2014. PMID: 24641665 Free PMC article.
-
Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells.Phytomedicine. 2012 May 15;19(7):603-8. doi: 10.1016/j.phymed.2012.01.003. Epub 2012 Feb 18. Phytomedicine. 2012. PMID: 22349030
-
[Anticancer effect of tanshinone and its mechanisms].Ai Zheng. 2003 Dec;22(12):1363-6. Ai Zheng. 2003. PMID: 14693071 Review. Chinese.
-
The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors.Biomed Pharmacother. 2024 Jun;175:116635. doi: 10.1016/j.biopha.2024.116635. Epub 2024 Apr 22. Biomed Pharmacother. 2024. PMID: 38653110 Review.
Cited by
-
A promising "TRAIL" of tanshinones for cancer therapy.Biomedicine (Taipei). 2015 Nov;5(4):23. doi: 10.7603/s40681-015-0023-8. Epub 2015 Nov 28. Biomedicine (Taipei). 2015. PMID: 26621311 Free PMC article.
-
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug.Front Oncol. 2023 Jan 31;13:1071415. doi: 10.3389/fonc.2023.1071415. eCollection 2023. Front Oncol. 2023. PMID: 36798821 Free PMC article. Review.
-
Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.Front Pharmacol. 2022 Sep 12;13:1008222. doi: 10.3389/fphar.2022.1008222. eCollection 2022. Front Pharmacol. 2022. PMID: 36172186 Free PMC article. Review.
-
Anti-cancer properties of specific Chinese herbal medicines for hepatocellular carcinoma treatment.Eur J Integr Med. 2020 Oct 3:101215. doi: 10.1016/j.eujim.2020.101215. Online ahead of print. Eur J Integr Med. 2020. PMID: 33042292 Free PMC article. Review.
-
Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses.Cancer Immunol Immunother. 2019 Jul;68(7):1073-1085. doi: 10.1007/s00262-019-02338-4. Epub 2019 Jun 3. Cancer Immunol Immunother. 2019. PMID: 31161238 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous